Yves Bikorimana: Before Wash vs After Wash in Blood Grouping
Yves Bikorimana, CEO at MedData-Rwanda and Lab Scientist at The University Teaching Hospital of Kigali-Chuk, shared a post on LinkedIn:
“Before Wash vs After Wash in Blood Grouping – Why It Matters
In immunohematology, small technical details can completely change interpretation. This image perfectly demonstrates the importance of the saline wash step during blood grouping and antibody testing.
Let’s break it down
Left Side: Tube Method (Cell Washing)
Before Wash
We see a red cell suspension with plasma and possible interfering substances still present. Proteins, rouleaux formation, or excess antibodies can create pseudo-agglutination or mask true reactions.
After 3× Saline Wash plus Centrifugation
The supernatant becomes clear, and only packed red cells remain at the bottom.
Why is this important?
- Removes unbound antibodies
- Eliminates excess plasma proteins
- Prevents false reactions
- Improves accuracy of antiglobulin testing
Washing ensures we are detecting true antigen–antibody reactions, not artifacts.
Right Side: Slide/Card Agglutination (Anti-A, Anti-B, Anti-D)
Before Wash
Anti-D appears weakly positive — but note the label: False agglutination.
Sometimes:
- Rouleaux formation
- Fibrin strands
- High protein states
- Improper cell suspension
can mimic agglutination.
After Wash
The false Anti-D reaction disappears.
Result interpretation becomes clear and reliable.
- Anti-A: Negative
- Anti-B: Negative
- Anti-D: Negative
Final Blood Group: O Rh(D) Negative
Key Takeaway
In transfusion medicine, accuracy is patient safety.
A simple saline wash step can:
- Prevent mislabeling of blood groups
- Avoid incompatible transfusions
- Reduce risk of hemolytic transfusion reactions
In laboratory science, precision isn’t optional — it’s ethical responsibility.”

Stay updated with Hemostasis Today.
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment
-
Sep 5, 2026, 19:13Amparo Santamaria: Stem Cells and Hematology – Unlocking a New Frontier in Ovarian Regeneration
-
Sep 5, 2026, 19:10Strengthening the Public Health System for Blood Disorders – Hemophilia Federation of America
-
Sep 5, 2026, 19:08Deidra D. Harris: Supporting Hemophilia of Georgia and the Bleeding Disorders Community
-
Sep 5, 2026, 19:06Katherine Blackwell: Blessed to Have the Opportunity to Speak at the Hemophilia of Indiana Annual Meeting
-
Sep 5, 2026, 19:04Christy V.: What You Need to Know about GI Bleeding and Hemophilia